Case Study: Global Pharmaceutical Company reduces linguistic validation timeline with Linguamatics

Delivering nine Clinical Outcome Assessments (COAs) for patients with cognitive impairments

A global pharmaceutical company faced a significant challenge when the initial two-week timeline for translating nine complex Clinical Outcome Assessments (COAs) for an Alzheimer's trial was vastly insufficient for the required 16-20 week linguistic validation process. The project involved cognitively demanding tests that required adaptation for languages like Japanese, which has a non-Latin alphabet and major cultural differences. They partnered with Linguamatics to find a solution.

Linguamatics implemented an agile project management approach, dividing critical tasks between specialized teams and leveraging their healthcare expertise. A key innovation was engaging a native-speaking clinician at the project's inception to guide translations and reviews, which minimized delays. As a result, Linguamatics successfully delivered the high-quality translations in just 12 weeks, a significant reduction from the standard timeline, ensuring the materials were ready for the Institutional Review Board.